Autoimmune hearing loss

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 5, Issue 5, 1997, Pages 276-282

  Harris, Jeffrey P ^a   Chen, Mien Chi ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOSUPPRESSIVE AGENT;

AGE; AUTOIMMUNITY; CLINICAL FEATURE; COCHLEA; DISEASE COURSE; FEMALE; HEARING LOSS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INNER EAR; MALE; MENIERE DISEASE; OTALGIA; PERCEPTION DEAFNESS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SEX RATIO; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; VERTIGO; WEGENER GRANULOMATOSIS;

EID: 0030699923     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/00020840-199710000-00003     Document Type: Review

References (66)

1. McCabe BF: Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979, 88:585-589.
2. Harris JP, Ryan AF: Fundamental immune mechanisms of the brain and inner ear. Otolaryngol Head Neck Surg 1995, 112:639-653.
3. Harris JP, Moscicki RA, Hughes GB: Immunologic disorders of the inner ear. In Otology edn 2 Edited by Hughes GB, Pensak ML. New York: Thieme; 1997:381-391. These authors provided an up-to-date review of scientific and clinical evidence of immunologie disorders of the inner ear. Emphasis on diagnostic work-up and therapeutic options are discussed.
4. Tomiyama S, Harris JP. Elevation of inner ear antibody levels following direct antigen challenge of the endolymphatic sac. Acta Otolaryngologica 1989, 107:202-209.
5. Rask-Andersen H, Stahle J: Immunodefence of the inner ear? Lymphocyte-macrophage interaction in the endolymphatic sac. Acta Oto-Laryngologica 1980, 89:283-294.
6. Mogi G, Lim D, Watanabe N: Immunologie study on the inner ear. Arch Otol 1982, 108:270-275.
7. Harris JP: Immunology of the inner ear: response of the inner ear to antigen challenge. Otolaryngol Head Neck Surg 1983, 91:18-32.
8. Harris JP: Immunology of the inner ear: evidence of local antibody production. Ann Otol Rhinol Laryngol 1984, 93:157-162.
9. Harris JP, Woolf NK, Ryan AF: The elaboration of systemic immunity following inner ear immunization. Am J Otolaryngol 1985, 6:148-52.
10. Takahashi M, Harris JP: Anatomic distribution and localization of immunocompetent cells in normal mouse endolymphatic sac. Acta Otolaryngol 1988, 106:409-416.
11. Takahashi M, Harris JP: Analysis of immunocompetent cells following inner ear stimulation. Laryngoscope 1988, 98:1133-1138.
12. Harris JP, Fukuda S, Keithley E: Spiral modiolar vein: its importance in inner ear inflammation. Acta Otolaryngol 1990, 110:357-365.
13. Stearns GS, Keithley E, Harris JP: Development of high endothelial venule-like characteristics in the spiral modiolar vein induced by viral labyrinthitis. Laryngoscope 1993, 103:890-898.
14. Takasu T, Harris JP: Anti-ICAM-1 therapy in experimental labyrinthitis. Ann Otol Rhinol Laryngol 1997, in press.
15. Tomiyama S, Harris JP: The endolymphatic sac: its importance in inner ear immune responses. Laryngoscope 1986, 96:685-691.
16. Harris JP, Woolf NK, Ryan AF, Butler DM, Richman, DD: Immunologic and electrophysiological response to cytomegaloviral inner ear infection in the guinea pig. J Infect Dis 1984, 150:523-530.
17. Woolf NK and Harris JP: Cochlear pathophysiology associated with inner ear immune responses. Acta Otolaryngol 1986, 102:353-364.
18. Darmstadt GL, Harris JP, Keithley EM: Effects of cyclophosphamide on the pathogenesis of cytomegalovirus-induced labyrinthitis. Ann Otol Rhinol Laryngol 1990, 99:960-968.
19. Chen MC, Harris JP, Kiethley E: Immunohistochemical analysis of proliferating cells in a sterile labyrinthitis animal model. Laryngoscope 1997, in press.
20. Paparella MM, Sugiura S: The pathology of suppurative labyrinthitis. Ann Otol Rhinol Laryngol 1967, 76:554-586.
21. Keithley EM, Harris JP: Late sequelae of cochlear infection. Laryngoscope 1996, 106:341-345.
22. Keithley EM, Chen MC, Linthicum F: Clinical diagnoses associated with histological findings of fibrotic tissue and new bone in the cochlea. Laryngoscope 1997, in press.
23. Veldman JE, Roord JJ, O'Connor AF, Shea JJ: Autoimmunity and inner ear disorders: an immune-complex mediated sensorineural hearing loss. Laryngoscope 1991, 101:225-229.
24. Derebery MJ, Rao VS, Siglock TJ, Linthicum FH, Nelson RA: Meniere's disease: an immune complex-mediated illness? Laryngoscope 1991, 101:225-229.
25. Garrigues HP, Carmona E, Morera C, Sanchez-Cuenca JM: Circulating auto-antibodies in Meniere's disease. Ann Otolaryngol Chir Cervicofac 1995, 112:225-228.
26. Kanzaki J, Inoue Y, O-Uchi T: Immunological findings of serological tests in steroid-responsive sensorineural hearing loss. Acta Oto Laryngologies 1994, 514(suppl):66-69.
27. Welling DB: Clinical evaluation and treatment of immune-mediated inner ear disease. Ear Nose Throat J 1996, 75:301-305. A well-written overview of the clinical presentation, diagnosis, and management of autoimmune inner ear disorders. Guidelines on immunosuppressive therapies are provided.
28. Standefer JA, Mattox DE: Head and neck manifestations of collagen vascular diseases. Otolaryngol Clin North Am 1986, 19:181-210.
29. Hughes GB, Barna BP, Kinney SE, Calabrese LH, Nalepa NJ: Clinical diagnosis of immune inner ear disease. Laryngoscope 1988, 98:251-253.
30. McCabe BF, McCormic KJ: Tests for autoimmune disease in otology. Am J Otol 1984, 5:447-449.
31. Lehnhardt E: Pützliche Hürstürungen, auf beiden Seiten gleichzeitig oder nacheinander aufgetreten. Z Laryngol Rhinol Otol 1958, 37:1-16.
32. Kikuchi M: On the sympathetic otitis. Zibi Rinsyo Kyoto 1959, 52:600.
33. Beickert P: Zur Frage der Empfindungsschwerhürigkeit und Autoallergie. Z Laryngol 1961, 54:837-842.
34. Terrayama Y, Sasaki Y: Studies on experimental allergic (isoimmune) labyrinthitis in guinea pigs. Acta Otolaryngol (Stockh) 1963, 58:49-85.
35. Yoo TJ, Yazawa Y, Tornoda K, Floyd R: Type II collagen-induced autoimmune endolymphatic hydrops in guinea pig. Science 1983, 222:65-67.
36. Takeda T, Sudo N, Kitano H, Yoo TJ: Type II collagen-induced autoimmune ear disease in mice: a preliminary report on an epitope of the type II collagen molecule that induced IE lesions. Am J Otol 1996, 17:69-75.
37. Hughes GB, Barna BP, Calabrese LH, Kinney SE, Nalepa NL: Predictive value of laboratory tests in autoimmune inner ear disease: preliminary report Laryngoscope 1986, 96:502-505.
38. Moscicki RA: Immune-mediated inner ear disorders. Baillieres Clin Neurol 1994, 3:547-563.
39. Arnold W, Pfaltz R, Altermatt HJ: Evidence of serum antibodies against inner ear tissues in the blood of patients with certain sensorineural hearing disorders. Acta Otolaryngol 1985, 99:437-444.
40. Rester D, Soliman AM: Autoimmune hearing loss. Am J Otol 1989, 10:188-192.
41. Harris JP, Sharp P: Inner ear autoantibodies in patients with rapidly progressive sensorineural hearing loss. Laryngoscope 1990, 100:516-24.
42. Harris JP: Experimental autoimmune sensorineural hearing loss. Laryngoscope 1987, 97:63-76.
43. Gottsclich S, Billings PB, Keithley EM, Weisman MH, Harris JP: Assessment of serum antibodies in patients with rapidly progressive sensorineural hearing loss and Meniere's disease. Laryngoscope 1995, 105:1347-1352.
44. Yamanobe S, Harris JP. Inner ear specific antibodies. Laryngoscope 1993, 103:319-25.
45. Yeo SW, Suh BD: Autoimmunity in inner ear disorders. Proc Sendai Symp 1995, 5:29-32.
46. Veldman JE, Hannada T, Meeuwsen F: Diagnostic and therapeutic dilemmas in rapidly progressive sensorineural hearing loss and sudden deafness. Acta Otolaryngol (Stockh) 1993, 113:303-306.
47. Moscicki RA, San Martin JE, Quintero CH, Rauch SD, Nadol JB Jr, Bloch KJ: Serum antibody to inner ear proteins in patients with progressive hearing loss. Correlation with disease activity and response to corticosteroid treatment JAMA 1994, 272:611-616.
48. Cao MY, Deggouj N, Gersdorff M, Tomasi JP: Guinea pig inner ear antigens: extraction and application to the study of human autoimmune inner ear disease. Laryngoscope 1996, 106(part 1):207-212.
49. Billings PB, Keithley EM, Harris JP Evidence linking the 68 kilodalton antigen identified in progressive sensorineural hearing loss patient sera with heat shock protein 70. Ann Otol Rhinol Laryngol 1995, 104:181-198.
50. Rauch SD, San Martin JE, Moscicki RA, Bloch KJ: Serum antibodies against heat shock protein 70 in Meniere's disease. Am J Otol 1995, 16:648-652.
51. Bloch KJ, San Martin JE, Rauch SD, Moscicki RA: Serum antibodies to heat shock protein 70 in sensorineural hearing loss. Arch Otolaryngol Head Neck Surg 1995, 121:1167-11 71.
52. Shin SO, Billings PB, Keithley EM, Harris JP: Comparison of anti-heat shock protein 70 (anti-hsp70) and anti-68-kDa inner ear protein in the sera of patients with Meniere's disease. Laryngoscope 1997, 107:222-227. These authors provided evidence that hsp70 and 68 kD antigen represent the same antigen. The authors describe a more easily standardizable assay for detecting autoantibody against the inner ear.
53. Ryan AF: Immunological factors in Meniere's disease. In Immunology of the Ear. Edited by Berstein J, Ogra P. New York: Raven Press 1987; 453-461.
54. Alleman AM, Dornhoffer JL, Arenberg IK, Walker PD: Demonstration of autoantibodies to the endolymphatic sac in Meniere's disease. Laryngoscope 1997, 107:211-215.
55. Suzuki M, Kitahara M. Immunologie abnormality in Meniere's disease. Otolaryngol Head Neck Surg 1992, 107:57-62.
56. Brookes GB: Circulating immune complexes in Meniere's disease. Arch Otolaryngol Head Neck Surg 1986, 112:536-540.
57. Evans KL, Baldwin DL, Bainbridge D, Morrison AW: Immune status in patients with Meniere's disease. Arch Otorhinolaryngol 1988, 245:287-292.
58. Derebery MJ: Allergic and immunologie aspects of Meniere's disease. Otolaryngol Head Neck Surg 1996, 114:360-365.
59. Harris JP, Nelman CL, House WF: Contralateral hearing loss following inner ear injury: sympathetic cochleolabyrinthitis? Am J Otol 1985, 6:371-377.
60. Harris JP, Aframian D: Role of autoimmunity in contralateral delayed endolymphatic hydrops. Am J Otol 1994, 15:710-716.
61. Silverstein H, Choo D, Rosenberg SI, Kuhn J, Seidman M, Stein I: Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report). Ear Nose Throat J 1996, 75:468-476. Preliminary report describing innovative means of administering steroids to achieve desired local effects in the inner ear for treatment of a variety of inner ear disorders.
62. Kim DW, Harris JP: Effects of direct depomedrol injection in to the endolymphatic sac (ES) during shunt surgery. Laryngoscope 1997, in press.
63. Sismanis A, Wise CM, Johnson GD: Methotrexate management of immunemediated cochleovestibular disorders. Otolaryngol Head Neck Surg 1997, 116:146-52. The authors report their experiences and outcomes of treatment with methotrexate for immunemediated inner ear diseases.
64. Sara Caydin A, Katircioglu S, Katircioglu S, Karatay MC: Azathioprine in combination with steroids in the treatment of autoimmune inner-ear disease. J Int Med Res 1993, 21:192-196.
65. Luetje CM. Theoretical and practical implications for plasmapheresis in autoimmune inner ear disease. Laryngoscope 1989, 99:1137-1146.
66. Brookes GB, Newland AC: Plasma exchange in the treatment of immune complex associated sensorineural deafness [abstract]. J Larngol Otol 1986, 100:25-33.